Skip to main content

Month: January 2024

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

Proceeds to be used for privately negotiated repurchases of common stock and outstanding 4.50% Convertible Senior Notes due 2025 MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) (the “Company”) today announced the pricing of its private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029 (the “Notes”). The Company granted the initial purchaser in the offering an option to purchase, within the 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $30.0 million aggregate principal amount of the Notes. The sale of the Notes is expected to close on January 9, 2024, subject to customary closing conditions. The Notes will be senior unsecured obligations of the Company, will bear interest at a rate of 3.75% per annum,...

Continue reading

Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock

WALTHAM, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 17,150,000 shares of its common stock at a public offering price of $17.50 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Dyne, are expected to be approximately $300.1 million. All shares in the offering are being sold by Dyne. The offering is expected to close on or about January 9, 2024, subject to customary closing conditions. In addition, Dyne has granted the underwriters a 30-day option to purchase up to an additional 2,572,500...

Continue reading

Voyager Therapeutics Announces Pricing of Public Offering

LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the pricing of an underwritten public offering of 7,777,778 shares of its common stock at a public offering price of $9.00 per share, and, to investors who so choose in lieu of common stock, pre-funded warrants to purchase an aggregate of 3,333,333 shares of common stock at a public offering price of $8.999 per pre-funded warrant, for aggregate gross proceeds of approximately $100 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The purchase price per pre-funded warrant represents the per share public offering price for the common stock, minus the $0.001 per share exercise price of each...

Continue reading

Standard BioTools Stockholders Approve Merger with SomaLogic

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic (Nasdaq: SLGC) at its Special Meeting of Stockholders. “We are pleased with the outcome of today’s Special Meeting and thank our stockholders for their support for this merger,” said Michael Egholm, PhD, President and Chief Executive Officer of Standard BioTools. “Together with SomaLogic, we will have an expanded platform to better serve our customers and we believe we will be able to deliver significant shareholder value through enhanced scale and a strengthened balance sheet to fuel future growth.” Standard...

Continue reading

FormFactor Inc. To Present At The 26th Annual Needham Growth Conference

LIVERMORE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 26th Annual Needham Growth Conference on January 17, 2024. FormFactor is scheduled to present on Wednesday, January 17 at 9:30AM ET. The company’s Chief Execute Officer, Michael Slessor, will present. The public is invited to listen to a live webcast of FormFactor’s presentations, which can be accessed from the investors’ section of the company’s website at www.formfactor.com. Replay of the webcast will also be available at www.formfactor.com. About FormFactor: FormFactor, Inc. (NASDAQ: FORM), is a leading provider of essential test and measurement technologies along the full IC life cycle -from characterization, modeling, reliability, and design de-bug, to qualification and production...

Continue reading

Dental Consumables Market Set to Soar Past USD 45.96 Billion by 2030

The global Dental Consumables market size is expected to reach USD 45.96 billion by 2030 and exhibit a CAGR of 7.8% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing global prevalence of dental disorders and oral health issues, including dental caries, periodontal diseases, and tooth loss, has created a growing demand for dental treatments and procedures, boosting the consumption of dental consumables. Secondly, the aging population, particularly in developed regions, has increased demand for dental care services and prosthetic solutions like dentures and dental implants, fueling the market’s growth. Westford USA, Jan. 04, 2024 (GLOBE NEWSWIRE) — SkyQuest’s latest global research of the Dental Consumables market shows a growing emphasis on preventive dentistry,...

Continue reading

Constellation Brands Announces Wine & Spirits Leadership Transition

Robert Hanson to Step Down as EVP & President, Wine & Spirits Division Effective February 29, 2024 Company Initiates Search to Identify New Leader to Guide Next Phase of Growth for Its Wine & Spirits Business VICTOR, N.Y., Jan. 04, 2024 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, today announced that the Company and Robert Hanson, who has led the transformation of the company’s Wine & Spirits business since 2019, have mutually agreed that Mr. Hanson will step down from his role as Executive Vice President and President of the company’s Wine & Spirits Division, at the end of Constellation’s fiscal year on February 29, 2024. The company has initiated a search to identify a successor. Bill Newlands, President and Chief Executive Officer, will assume responsibilities...

Continue reading

Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2023 Operating Results

DALLAS, Jan. 04, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the full year and fourth quarter of 2023 before market on Thursday, January 18, 2024. Executive management will host a conference call and webcast to discuss full year and fourth quarter 2023 operating results on Thursday, January 18, 2024, at 9:00 a.m. EDT. Participants may pre-register for the call by visiting https://www.netroadshow.com/events/login?show=a5b5e3ea&confId=59474 and will receive a unique PIN number to be used when dialing in for the call for immediate access. Alternatively, participants may call 833.470.1428 and use the access code 049214 at least fifteen minutes prior to the call to join through an operator. The live...

Continue reading

CORRECTION – Alpine Income Property Trust Announces 2023 Transaction Activity and Provides Corporate Update

WINTER PARK, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Alpine Income Property Trust, Inc. (NYSE: PINE), please note that in the last bullet of the “2023 Investment Activity” list, the weighted average initial investment yield should be 9.1%, not 7.9% as previously stated. The corrected release follows: Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) today announced its 2023 investment and disposition activities and provided a corporate update. 2023 Investment ActivityDuring the year ended December 31, 2023, the Company acquired 14 net lease retail properties for total acquisition volume of $82.9 million, representing a weighted average going-in cash cap rate of 7.4%. Acquisitions completed during the year had a weighted average remaining lease...

Continue reading

Madison Pacific Properties Inc. announces Tax Court of Canada judgement on tax court case

VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces judgement issued by the Tax Court of Canada (“TCC”) on its tax court case. As previously reported in the Company’s Consolidated Financial Statements, the Company and certain subsidiaries have received from the Canada Revenue Agency (“CRA”) and Alberta Tax and Revenue Administration (“ATRA”) tax notices of reassessment for various taxation years. The reassessments deny the application and usage of certain non-capital losses, capital losses, deductions and investment tax credits arising from prior years. The Company and its subsidiaries have filed notices of objection and notices of appeal to the reassessments with the CRA and ATRA. The appeal with the Tax...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.